JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -91.73%115.21M | 9,678.39%1.33B | 9,460.69%1.39B | -91.39%13.63M | -90.40%14.57M | -74.99%158.35M | -69.17%151.73M | -22.25%633.18M | -53.97%492.07M | 366.37%814.43M |
Operating income | -91.73%115.21M | 9,678.39%1.33B | 9,460.69%1.39B | -91.39%13.63M | -90.40%14.57M | -74.99%158.35M | -69.17%151.73M | -22.25%633.18M | -53.97%492.07M | 366.37%814.43M |
Cost of sales | 33.76%-185.56M | -301.44%-426.53M | -457.51%-280.12M | 51.58%-106.25M | 69.81%-50.25M | 66.32%-219.44M | 54.38%-166.45M | -38.35%-651.5M | 39.64%-364.88M | -451.96%-470.92M |
Operating expenses | 33.76%-185.56M | -301.44%-426.53M | -457.51%-280.12M | 51.58%-106.25M | 69.81%-50.25M | 66.32%-219.44M | 54.38%-166.45M | -38.35%-651.5M | 39.64%-364.88M | -451.96%-470.92M |
Gross profit | -106.32%-70.35M | 1,078.46%906.26M | 3,220.54%1.11B | -51.61%-92.62M | -142.22%-35.67M | -233.38%-61.09M | -111.58%-14.73M | -105.33%-18.33M | -72.62%127.19M | 284.61%343.51M |
Selling expenses | 52.84%-153.39M | -5,635.56%-319.36M | -7,987.27%-325.27M | 77.35%-5.57M | 79.01%-4.02M | 78.33%-24.59M | 61.71%-19.16M | -162.21%-113.47M | -611.26%-50.04M | -66.71%-43.27M |
Administrative expenses | 14.61%-54.07M | -12.08%-138.22M | -11.85%-63.32M | 12.27%-123.32M | -0.40%-56.61M | -1.47%-140.56M | -4.42%-56.39M | -4.17%-138.52M | 2.80%-54M | 34.66%-132.98M |
Impairment and provision | ---- | 60.15%-3.38M | ---- | -750.80%-8.49M | ---- | 89.21%-998K | ---- | ---9.25M | ---- | ---- |
-Other impairment is provision | ---- | 60.15%-3.38M | ---- | -750.80%-8.49M | ---- | 89.21%-998K | ---- | ---9.25M | ---- | ---- |
Special items of operating profit | 171.03%187.53M | -2,743.90%-232.43M | -28,671.32%-264M | 81.97%8.79M | 118.06%924K | -89.14%4.83M | -133.05%-5.12M | 133.40%44.5M | 78.23%15.48M | 107.05%19.07M |
Operating profit | -119.60%-90.28M | 196.23%212.87M | 582.87%460.57M | 0.54%-221.21M | 0.00%-95.38M | 5.39%-222.41M | -346.94%-95.39M | -226.16%-235.07M | -90.59%38.63M | 145.39%186.32M |
Financing income | 20.18%1.51M | 7.60%4.14M | -53.49%1.25M | -54.51%3.84M | -32.16%2.7M | 129.21%8.45M | 355.73%3.97M | 21.44%3.69M | -63.02%872K | 333.10%3.04M |
Financing cost | 92.49%-329K | 16.63%-4.92M | -390.48%-4.38M | 2.61%-5.91M | 84.59%-893K | 30.91%-6.06M | -723.15%-5.8M | -176.81%-8.78M | 71.42%-704K | 80.78%-3.17M |
Earning before tax | -119.48%-89.1M | 194.99%212.09M | 588.83%457.44M | -1.48%-223.27M | 3.73%-93.58M | 8.38%-220.02M | -350.56%-97.21M | -228.99%-240.16M | -90.55%38.8M | 143.68%186.19M |
Tax | 100.10%55K | -3,726.71%-52.95M | ---56.67M | 109.40%1.46M | ---- | ---15.54M | ---- | ---- | 79.24%-18.46M | -339.96%-81.08M |
After-tax profit from continuing operations | -122.22%-89.05M | 171.74%159.14M | 528.27%400.77M | 5.84%-221.81M | 3.73%-93.58M | 1.92%-235.56M | -577.93%-97.21M | -328.49%-240.16M | -93.67%20.34M | 123.64%105.11M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 94,250.00%3.77M | ---8K | ---4K |
Earning after tax | -122.22%-89.05M | 171.74%159.14M | 528.27%400.77M | 5.84%-221.81M | 3.73%-93.58M | 0.35%-235.56M | -578.12%-97.21M | -324.91%-236.39M | -93.68%20.33M | 123.63%105.1M |
Profit attributable to shareholders | -122.22%-89.05M | 171.74%159.14M | 528.27%400.77M | 5.84%-221.81M | 3.73%-93.58M | 0.35%-235.56M | -578.12%-97.21M | -324.91%-236.39M | -93.68%20.33M | 123.63%105.1M |
Basic earnings per share | -118.18%-0.02 | 166.67%0.04 | 466.67%0.11 | 14.29%-0.06 | 0.00%-0.03 | 0.00%-0.07 | -400.00%-0.03 | -333.33%-0.07 | -90.91%0.01 | 118.75%0.03 |
Diluted earnings per share | -118.18%-0.02 | 166.67%0.04 | 466.67%0.11 | 14.29%-0.06 | 0.00%-0.03 | 0.00%-0.07 | -400.00%-0.03 | -333.33%-0.07 | -90.91%0.01 | 118.75%0.03 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.